Patent · US Active

Pyrazolylaminopyridine derivatives useful as kinase inhibitors

US8324252B2 · kind B2 · utility

0Cited by

0References

3Claims

0Family size

Assignee

ASTRAZENECA AB · SE

Inventors

Audrey Davies · Arlington, US
Michelle Lamb · Waltham, US
Paul Lyne · Arlington, US
Tao Wang · Farmington, US
Dingwei Yu · Easton, US
Peter Mohr · Basel, CH
Bin Wang · Beijing, CN

Key dates

Filing date	Feb 1, 2006
Grant date	Dec 4, 2012
Priority date	—
Expiry date	May 17, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

This invention relates to novel compounds having the Formula (I) to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment for cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.